Kestra Medical Technologies, Ltd. (KMTS) vs Stoke Therapeutics, Inc. (STOK)
A side-by-side comparison of Kestra Medical Technologies, Ltd. and Stoke Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KMTS
Kestra Medical Technologies, Ltd.
$27.10HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
STOK
Stoke Therapeutics, Inc.
$24.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — KMTS vs STOK
growth of $100 · dividends reinvested · last 2yKMTS +29.8% (+13.9%/yr)STOK +210.7% (+76.3%/yr)STOK compounded faster over this window
KMTS STOK
KMTS vs STOK: by the numbers
- •KMTS is the larger company ($1.59B vs $1.57B market cap).
- •Both run net losses; KMTS's is the smaller (-140.43% vs -753.60% net margin).
Metrics side by side
Valuation
| Metric | KMTS | STOK |
|---|---|---|
| P/S ratio | 14.88 | 57.00 |
| P/B ratio | 7.14 | 4.55 |
Profitability
| Metric | KMTS | STOK |
|---|---|---|
| Gross margin | 53.89% | 100.00% |
| Operating margin | -134.48% | -11.16% |
| Net margin | -140.43% | -753.60% |
| ROE | -67.40% | -60.17% |
| ROIC | -47.99% | -63.12% |
Growth (annualized)
| Metric | KMTS | STOK |
|---|---|---|
| Total return CAGR (5Y) | N/A | -0.24% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.